Alivus Life Sciences Limited has informed the Exchange about Schedule of Analyst / Institutional Investor meeting.
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences Limited has informed the exchanges about a scheduled meeting with Millennium Capital Management on March 17, 2026. The meeting will be held in-person in Mumbai in a one-on-one format. This is a routine disclosure filed under SEBI Listing Regulations to keep the market informed of investor engagements. The company noted that the schedule or mode may change due to unforeseen circumstances.
This is a routine regulatory disclosure and does not indicate any material business development. The meeting with a single institutional investor is a normal part of investor relations activity and is unlikely to have a direct impact on the stock price.